A new wearable wristband could significantly improve diabetes management by continuously tracking not only glucose but also ...

Objective Phase II trials suggest glucagon-like peptide-1 receptor (GLP1) agonists resolve metabolic dysfunction-associated steatohepatitis but do not affect fibrosis regression. We aimed to determine ...

Objective Heart failure (HF) is a malignant condition requiring urgent treatment. Guidelines recommend natriuretic peptide (NP) testing in primary care to prioritise referral for specialist diagnostic ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Elevated CRP levels are now described before the onset of type 1 diabetes and have previously been described before the onset of type 2 diabetes [12] and gestational diabetes. [3] ...